153 related articles for article (PubMed ID: 36732734)
1. Study protocol of an international patient-led registry in patients with pulmonary fibrosis using online home monitoring: I-FILE.
Nakshbandi G; Moor CC; Antoniou K; Cottin V; Hoffmann-Vold AM; Koemans EA; Kreuter M; Molyneaux PL; Wuyts WA; Wijsenbeek MS
BMC Pulm Med; 2023 Feb; 23(1):51. PubMed ID: 36732734
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study.
Barth S; Edwards C; Saini G; Haider Y; Williams NP; Storrar W; Jenkins G; Stewart I; Wickremasinghe M
Respir Res; 2024 Apr; 25(1):162. PubMed ID: 38622608
[TBL] [Abstract][Full Text] [Related]
4. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.
Kahlmann V; Janssen Bonás M; Moor CC; van Moorsel CHM; Kool M; Kraaijvanger R; Grutters JC; Overgaauw M; Veltkamp M; Wijsenbeek MS;
BMC Pulm Med; 2020 Oct; 20(1):271. PubMed ID: 33076885
[TBL] [Abstract][Full Text] [Related]
5. Study protocol for connective tissue disease-associated interstitial lung disease trial (TEL-CTD-ILD): A randomized controlled trial of a home-based telemonitoring of treatment effects.
Małysiak-Szpond S; Mozga M; Miądlikowska E; Miłkowska-Dymanowska J; Białas AJ; Piotrowski WJ
PLoS One; 2022; 17(12):e0278601. PubMed ID: 36574413
[TBL] [Abstract][Full Text] [Related]
6. Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.
Moor CC; Mostard RLM; Grutters JC; Bresser P; Aerts JGJV; Chavannes NH; Wijsenbeek MS
Am J Respir Crit Care Med; 2020 Aug; 202(3):393-401. PubMed ID: 32325005
[No Abstract] [Full Text] [Related]
7. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
[TBL] [Abstract][Full Text] [Related]
8. REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease.
Barth S; Edwards C; Borton R; Beever D; Adams W; Jenkins G; Pizzo E; Stewart I; Wickremasinghe M
BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38418384
[TBL] [Abstract][Full Text] [Related]
9. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
10. Home monitoring of lung function, symptoms and quality of life after admission with COVID-19 infection: The HOMECOMIN' study.
Nakshbandi G; Moor CC; Nossent EJ; Geelhoed JJM; Baart SJ; Boerrigter BG; Aerts JGJV; Nijman SFM; Santema HY; Hellemons ME; Wijsenbeek MS
Respirology; 2022 Jul; 27(7):501-509. PubMed ID: 35441433
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of online home spirometry in systemic sclerosis-associated interstitial lung disease: a pilot study.
Moor CC; van Leuven SI; Wijsenbeek MS; Vonk MC
Rheumatology (Oxford); 2021 May; 60(5):2467-2471. PubMed ID: 33212511
[TBL] [Abstract][Full Text] [Related]
12. Remote Patient Monitoring and Teleconsultation to Improve Health Outcomes and Reduce Health Care Utilization of Pediatric Asthma (ALPACA Study): Protocol for a Randomized Controlled Effectiveness Trial.
van der Kamp M; Hengeveld V; Willard N; Thio B; de Graaf P; Geven I; Tabak M
JMIR Res Protoc; 2023 Jul; 12():e45585. PubMed ID: 37399066
[TBL] [Abstract][Full Text] [Related]
13. Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures.
Wijsenbeek M; Molina-Molina M; Chassany O; Fox J; Galvin L; Geissler K; Hammitt KM; Kreuter M; Moua T; O'Brien EC; Slagle AF; Krasnow A; Reaney M; Baldwin M; Male N; Rohr KB; Swigris J; Antoniou K
ERJ Open Res; 2022 Apr; 8(2):. PubMed ID: 35509443
[TBL] [Abstract][Full Text] [Related]
14. Use of the patientMpower App With Home-Based Spirometry to Monitor the Symptoms and Impact of Fibrotic Lung Conditions: Longitudinal Observational Study.
Edwards C; Costello E; Cassidy N; Vick B; Russell AM
JMIR Mhealth Uhealth; 2020 Nov; 8(11):e16158. PubMed ID: 33216007
[TBL] [Abstract][Full Text] [Related]
15. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
16. The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease.
Khan F; Stewart I; Howard L; McKeever TM; Jones S; Hearson G; Braybrooke R; Edwards C; Jenkins G; Saini G
BMJ Open Respir Res; 2019; 6(1):e000439. PubMed ID: 31258922
[TBL] [Abstract][Full Text] [Related]
17. Is It Possible to Have Home E-Monitoring of Pulmonary Function in Our Patients with Duchenne Muscular Dystrophy in the COVID-19 Pandemic?-A One Center Pilot Study.
Wasilewska E; Sobierajska-Rek A; Małgorzewicz S; Soliński M; Szalewska D; Jassem E
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501557
[TBL] [Abstract][Full Text] [Related]
18. Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases.
Swigris JJ; Bushnell DM; Rohr K; Mueller H; Baldwin M; Inoue Y
BMJ Open Respir Res; 2022 Mar; 9(1):. PubMed ID: 35241434
[TBL] [Abstract][Full Text] [Related]
19. Variability of forced vital capacity in progressive interstitial lung disease: a prospective observational study.
Veit T; Barnikel M; Crispin A; Kneidinger N; Ceelen F; Arnold P; Munker D; Schmitzer M; Barton J; Schiopu S; Schiller HB; Frankenberger M; Milger K; Behr J; Neurohr C; Leuschner G
Respir Res; 2020 Oct; 21(1):270. PubMed ID: 33076914
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
